Presence of PAF-Acether in Human Breast Carcinoma: Relation to Axillary Lymph Node Metastasis
- 6 September 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 81 (17) , 1298-1302
- https://doi.org/10.1093/jnci/81.17.1298
Abstract
PAF-acether (PAF; formerly platelet-activating factor), a potent lipid mediator of inflammation, is involved in multiple cellular functions. To evaluate the role of PAF in human cancer, we obtained specimens from patients with localized breast carcinoma and assayed them for PAF. PAF was found in almost all carcinoma, although it was not detected in most of the matched, nontumor breast tissue samples. Intratumor PAF level was elevated when axillary lymph node involvement was low. Greater axillary extension (two or more positive lymph nodes) was associated with a decreased intratumor PAF level. These findings, along with the independence of other prognostic factors, indicate that PAF is a tumor marker of axillary lymph node involvement. [J Natl Cancer Inst 81:1298–1302, 1989]Keywords
This publication has 5 references indexed in Scilit:
- Immunoregulatory functions of paf-acether II. Decrease of CD2 and CD3 antigen expressionEuropean Journal of Immunology, 1988
- Reduction to Homozygosity of Genes on Chromosome 11 in Human Breast NeoplasiaScience, 1987
- Induction of Membrane Ruffling and Fluid-Phase Pinocytosis in Quiescent Fibroblasts by ras ProteinsScience, 1986
- Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988European Journal of Pharmacology, 1986
- The influence of alkyl-lysophospholipids and lysophospholipid-activated macrophages on the development of metastasis of 3-Lewis lung carcinomaPublished by Elsevier ,1980